Patent ID: 6864270

Claim:
A pharmaceutical composition comprising a compound represented by formula (I) or (V), in combination with a pharmaceutically acceptable excipient, wherein formulas (I) and (V) are where: R is OH, OR 7 , or N(OH)R 8 ; R 1 is H, CH 3 or absent; R 2 is H, CH 3 or absent, provided that R 1 and R 2 are not both absent; R 3 is H or CH 3 , or R 3 is absent when one of R 1 or R 2 is absent forming a double bond between the R 1 /R 2 carbon and the R 3 carbon; R 4 is H, acyl of 1-4 carbons or alkyl of 1-4 carbons; R 5 is ((CH 2 ) a (R 10 )) b (CH 2 ) a R 10 ((CH 2 ) a (R 10 )) b X; R 6 is H, OH, alkyl of 1-6 carbons or a halogen, or R 6 is —C═C—C═C—, which, together with R 11 forms a fused ring system as follows: R 7 is alkyl of one to four carbons or optionally substituted benzyl; R 8 is H, alkyl of one to four carbons, optionally substituted benzyl, or R 9 is H, alkyl of one to tour carbons or optionally substituted benzyl; R 10 is O or CH 2 ; R 11 is H, OH, O-acyl of 1-4 carbons or O-alkyl of 1-4 carbons or R 11 is part of a fused ring system when R 6 is —C═C—C═C—; A is CH or C(OH); B is S, O, N or CH 2 ; a is 2 or 3; b is 0 or 1; m is an integer from 1 to 8; n is 0 or 1; p is 0, 1 or 2; and X is wherein each of the substituents shown is defined above, or a pharmaceutically acceptable salt of the compound represented by formula (I) or (V) or a stereoisomer of the compound or mixture of stereoisomers.